Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients.

Davide Santagata G Cammà Marco Paolo Donadini Alessandro Squizzato Walter Ageno

Published in: Expert opinion on pharmacotherapy (2022)

Thanks to the potentially favorable safety profile, factor XI inhibitors may play a role in the prevention of VTE in this setting. The expert opinion section discusses pharmacological properties, prophylaxis trials, and potential clinical applications of this novel class of drugs.

Keyphrases

venous thromboembolism
direct oral anticoagulants
healthcare
drug induced
clinical practice
climate change
atrial fibrillation